Krensavage Asset Management Opposes Sun's Lowball Bid for Taro
Sun, a
Sun's inadequate offer amounts to a
Taro boasts more than just cash and real estate. The maker of generic creams and ointments generated
Not only is Sun failing to offer a control premium, but it also seemingly ignores Taro's 22 generic drugs awaiting clearance in the
With a market value of
Taro's actions suggest it agrees with our assessment. In December 2019, Taro paid
Sun's tactics ring familiar. In October 2011, it lowballed Taro's shareholders with a
Sun requires approval of the majority of Taro's minority shareholders. Unless Sun acknowledges Taro's value, we refuse to support the transaction.
Notes:
1Krensavage Asset Management's 641,910 shares of Taro on March 31 make it Taro's No. 2 shareholder, according to Bloomberg.
2Tangible assets equal assets of
3Krensavage defines Taro's net cash as current assets of
4Bloomberg lists Sun's closing market cap on July 13 as
5Taro had 37,584,631 shares outstanding as of March 31. Sun controlled 29,497,813 shares of Taro according to Sun's May 26 13D/A.
Contact:
David W. Walbert
Senior Analyst
Krensavage Asset Management LLC
Office: (212) 706-0589
View original content:https://www.prnewswire.com/news-releases/krensavage-asset-management-opposes-suns-lowball-bid-for-taro-301880370.html
SOURCE Krensavage Asset Management LLC